COMING SOON - The Onion News Network @ Parker Playhouse Sun. March 10, 2013 Giving new meaning to "journalistic excellence," The Onion has grown from a student newspaper to a major "news" network with 2 million readers per week of their in-print headlines alone and over 40 million webpage views per month. They have been described as "arguably the most popular humor periodical in world history" by The New Yorker and have won the Webby Awards on 23 occasions based on their online publication. The Onion brings humor and intellect into every live engagement and this exclusive Florida engagement is no exception - tackling the important stories which most won't dare to cover, such as "Drugs Win Drug War" and "Black Man Given Nation's Worst Job." Brace yourselves for witty, gut-busting controversial topics pertaining to South Florida crafted specially for this show! PLUS -- special guest opening act returning to his hometown just for this show, one of South Florida's most revered stand-up comedians, - Adrian Mesa. VIP tickets includes after-show meet greet, complimentary food and beverage, commemorative gift optional autograph By: stephen sterlin … Continue reading →

Cold World - BuCkk TheGoblin [Drugs Politics] By: BuCkk TheGoblin … Continue reading →

Learn 2 Key Things You Must Do To Lose Weight and Gain Energy Dr. Serpe of the NeuroPlus Institute in Naperville Illinois shares 2 key things that you must do to lose weight and gain energy through one of his patients. Learn how thyroid and sex hormone imbalances and inflammation can literally "gum up" your metabolic machinery causing you to gain weight and feel tired. Linda lost 17 pounds in 6 weeks without feeling deprived because she got healthy. After lab work showed she was post menopausal and had significant imbalances in her metabolism Dr. Serpe created a specific program to bring her physiology into alignment naturally, safely, and without drugs or hormones. It really is possible to for you reclaim your life again. You can have energy, sleep well, maintain a normal healthy body weight, think clearly and have motivation to engage in real living...at any age. Watch this video to learn more about how Linda found all that and more by working with Dr. Serpe. http://www.napervillethyroid.com http://www.napervillebbt.com Joseph M. Serpe, DC 651 Amersale Drive, Suite 109 Naperville, IL 60563 (630) 357-2299 By: Joseph Serpe … Continue reading →

My Last Words Casting Call 2 (Auditions Open) HD! IGNORE THE MESSAGE IN THE BEGINNING! :/ My Last Words is in need of 2 replacement voice actresses! This means...if you get the role - it is yours until this series is completed. We need you to be dedicated since this series will take time due to our (LshineBLight and LunarFoxxFire's) busy schedules....we need you to stay COMMITTED! We also want you to respond to our messages! PM's, Emails and any other ways we can keep in contact with you! If you audition you must be able to hand in lines as soon as possible. (This is for the first episode if you get the role of Judith we will need your lines ASAP!) Megan comes in a bit later... RULES! In video! Note: YOU MUST be able to swear Talk about sex, drugs and alcohol Say each line 3 times. LINES! Include you SCREAMING, CRYING, LAUGHING and PANIC NOISES in you audition. Judith: Friends with Jessica and Ally - form the 3 bitches. Sarcastic and bitchy. 1. (Bitchy) That's cute, trying to make peace. But darling, we both know the world will be a far better place … Continue reading →

Drug Dealer Dreams - BuCkk TheGoblin [Drugs Politics] By: BuCkk TheGoblin … Continue reading →

TRENTON, N.J. (AP) -- Shares of drugmaker Merck & Co. declined Monday after two analysts downgraded their ratings, mainly due to worries that results of patient studies could hurt prospects for a few drugs and drag down future revenue and profit. The drugs involved are in two areas where Merck was a pioneer, eventually got hit with generic competition and has since been trying to regain leadership. The company invented the first widely used pills for treating osteoporosis, with its Fosamax, and controlling high cholesterol, with Mevacor, the first drug in the blockbuster class called statins that includes Pfizer Inc.'s Lipitor. Mevacor's successor, Zocor, was an even bigger seller for Merck, with annual revenue of about $5 billion. Future sales of Vytorin, a controversial combination drug on sale since 2004 that includes Zocor, and prospects for a crucial experimental osteoporosis drug called odanacatib were thrown into question Friday as Merck announced its fourth-quarter results. Company executives made some cryptic comments, suggesting significant problems with both drugs. Merck shares fell 98 cents, or 2.3 percent, to close at $40.85. Merck, based in Whitehouse Station, N.J., said Friday that it won't apply for approval of odanacatib, a new type of osteoporosis drug, … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/wb9lqv/global_anesthesia) has announced the addition of the "Global Anesthesia Drugs Market 2012-2016" report to their offering. TechNavio's analysts forecast the Global Anesthesia Drugs market to grow at a CAGR of 2.53 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in the number of emergency surgeries. The Global Anesthesia Drugs market has also been witnessing the pediatrics applications of anesthesia. However, the allergic reactions in anesthesia could pose a challenge to the growth of this market. The key vendors dominating the Anesthesia Drugs market space are Abbott Laboratories, AstraZeneca PLC, and Baxter International Inc. The other vendors mentioned in the report are Celgene Corporation, Claris Life Sciences, Eisai Co. Ltd., Endo Pharmaceuticals Inc., Halocarbon Products Corp., Hospira Inc., Merck and Co., Piramal Healthcare, and Roche Diagnostics. Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Earlier, vendors manufactured gender-neutral anesthesia drugs. Nowadays, sex-based anesthesia drugs are being introduced into the market to address the concerns related to perioperative anesthetic care for both sexes. This trend has a strong impact on the market.'' According to the report, one of the main drivers in this market … Continue reading →

NEW YORK (AP) -- Idenix Pharmaceuticals Inc. said Monday that it is ending development of two hepatitis C drugs after regulators told the biopharmaceutical company the drugs would remain on clinical hold. Shares of the Cambridge, Mass.-based company fell in after-hours trading. The two Idenix drugs, IDX184 and IDX19368, as well as another drug from Bristol-Myers Squibb Co. called BMS-986094, work in similar ways. All three products are nucleotide inhibitors, meaning they are designed to prevent the hepatitis C virus from making copies of itself. In August Bristol-Myers halted testing of BMS-986094 after one patient in the clinical trial died of heart failure following treatment. The drugmaker eventually abandoned development of the product. Idenix has said there are important differences between the drugs, but the Food and Drug Administration placed IDX184 on clinical hold Aug. 16. At the time, it was Idenix's most advanced experimental drug. The FDA also had placed a hold on IDX19368, which hadn't begun patient dosing. The company submitted cardiac safety data on IDX184 to the FDA in December, but said Monday it received word from the FDA this month that the programs for both IDX184 and IDX19368 would remain on hold. Shares of the company … Continue reading →